持续性ST段抬高型急性心肌梗死患者的管理：欧洲心脏病学会ST段抬高型急性心肌梗死管理工作组 - Suppr | 超能文献

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

作者信息

Van de Werf Frans, Bax Jeroen, Betriu Amadeo, Blomstrom-Lundqvist Carina, Crea Filippo, Falk Volkmar, Filippatos Gerasimos, Fox Keith, Huber Kurt, Kastrati Adnan, Rosengren Annika, Steg P Gabriel, Tubaro Marco, Verheugt Freek, Weidinger Franz, Weis Michael

机构信息

Department of Cardiology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium.

出版信息

Eur Heart J. 2008 Dec;29(23):2909-45. doi: 10.1093/eurheartj/ehn416. Epub 2008 Nov 12.

DOI:10.1093/eurheartj/ehn416

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

Eur Heart J. 2008 Dec;29(23):2909-45. doi: 10.1093/eurheartj/ehn416. Epub 2008 Nov 12.

2

Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Eur Heart J. 2003 Jan;24(1):28-66. doi: 10.1016/s0195-668x(02)00618-8.

3

Thrombolytic therapy for acute ST-segment elevation myocardial infarction: should it be given to all patients prior to urgent PCI?

Clin Cardiol. 2006 Mar;29(3):93-5. doi: 10.1002/clc.4960290302.

4

Is routine early invasive management of non-ST-segment elevation myocardial infarction beneficial in elderly patients?

CMAJ. 2004 Oct 26;171(9):1046-7. doi: 10.1503/cmaj.1041543.

5

The early days after ST-segment elevation acute myocardial infarction: reconsidering the delayed invasive approach.

J Am Coll Cardiol. 2003 Aug 6;42(3):420-3. doi: 10.1016/s0735-1097(03)00644-2.

6

Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

Eur Heart J. 1996 Jan;17(1):43-63. doi: 10.1093/oxfordjournals.eurheartj.a014691.

7

Should primary angioplasty be available for all patients with an ST elevation myocardial infarction?

Heart. 2005 Dec;91(12):1509-11. doi: 10.1136/hrt.2004.059485. Epub 2005 May 27.

8

[Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].

Herz. 2010 Dec;35(8):558-64. doi: 10.1007/s00059-010-3401-8.

9

[V Guideline of the Brazilian Society of Cardiology on Acute Myocardial Infarction Treatment with ST Segment Elevation].

Arq Bras Cardiol. 2015 Aug;105(2 Suppl 1):1-105. doi: 10.5935/abc.20150107.

10

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).

J Am Coll Cardiol. 2004 Aug 4;44(3):671-719. doi: 10.1016/j.jacc.2004.07.002.

引用本文的文献

1

Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention.

BMC Cardiovasc Disord. 2025 Jul 5;25(1):494. doi: 10.1186/s12872-025-04953-9.

2

Mon4 as a novel monocyte subset with distinct profile and predictor of poor outcomes in individuals with myocardial infarction.

J Thromb Thrombolysis. 2025 May 26. doi: 10.1007/s11239-025-03111-4.

3

Validation of Decisions for Percutaneous Coronary Intervention Using Smartphone-Based Electrocardiogram Device Spandan: A Cross-Sectional Observational Study.

Cardiol Res. 2025 Jun;16(3):225-237. doi: 10.14740/cr2051. Epub 2025 May 7.

4

Comparison of complete vs. culprit-only revascularization in acute myocardial infarction.

BMC Cardiovasc Disord. 2025 Apr 25;25(1):325. doi: 10.1186/s12872-025-04777-7.

5

Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction.

BMC Cardiovasc Disord. 2025 Mar 20;25(1):204. doi: 10.1186/s12872-025-04667-y.

6

Prognostic Significance of Homocysteine Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Propensity Score Matching and Weighting Analysis.

Rev Cardiovasc Med. 2025 Feb 19;26(2):25518. doi: 10.31083/RCM25518. eCollection 2025 Feb.

7

Enhanced fibrotic potential of COL1A1NR4A1 fibroblasts in ischemic heart revealed by transcriptional dynamics heterogeneity analysis at both bulk and single-cell levels.

Front Cardiovasc Med. 2025 Jan 6;11:1460813. doi: 10.3389/fcvm.2024.1460813. eCollection 2024.

8

Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction.

BMC Cardiovasc Disord. 2024 Nov 30;24(1):691. doi: 10.1186/s12872-024-04364-2.

9

Role of Mechanical Circulatory Support in Acute MI Management.

US Cardiol. 2023 Apr 28;17:e04. doi: 10.15420/usc.2022.32. eCollection 2023.

10

Left atrial volume assessed by echocardiography identifies patients with high risk of adverse outcome after acute myocardial infarction.

Echo Res Pract. 2024 Oct 21;11(1):24. doi: 10.1186/s44156-024-00060-1.